Researcher Wants Federal Court To Halt DEA Cannabis Rescheduling Hearings Over Allegations Of Illegal Proceedings And Agency Bias | Cannabis Law Report | Where to buy Skittles Moonrock online

Learn where to order CBD Oil online. TOP QUALITY GRADE A++

Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.

👉 Click here to Visit our shop! 🛒

It looks like the US is awkening again from it’s post election..”what the fuck happens next” self induced slumber…

Well.. this is what happens next.. back to litigation it’s the bread and beutter of the country’s legal system.

Marijuana Moment

A marijuana and psychedelics researcher has filed a lawsuit in federal court alleging that the Drug Enforcement Administration (DEA) violated multiple laws in setting a hearing to further consider the Biden administration’s cannabis rescheduling proposal—and he’s asking for an order halting the proceedings until those issues are resolved.

In a complaint filed with the U.S. District Court for the Western District of Washington on Monday, Panacea Plant Sciences founder and CEO David Heldreth laid out several allegations against DEA that he says warrant judicial intervention in the agency’s plans to hold an administrative hearing on the Justice Department’s proposal to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA).

An initial hearing is currently scheduled for December 2, coming months after a public comment period closed. Panacea was among numerous organizations that requested to participate in the hearing, but it was not among the 25 witnesses selected by DEA Administrator Anne Milgram late last month.

Read more